Genetic Technologies Ltd has released a press release.
US Patent Office Grants Foundational Pharmacogenomic Patent
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- GTG COVID-19 Risk Test launched in USA
- COVID- 19 Risk Test Approved for Commercial Release
- GTG signs 3-year US licence agreement for COVID risk test
- Pause in Trading
- 1H21 Half Year Results
Later from Genetic Technologies
- Genetic Technologies Acquires EasyDNA
- Genetic Technologies Investor Presentation and Webinar
- Completion of EasyDNA Acquisition set for global expansion
- Genetic Technologies FY21 Full Year Results
- Presentation to H.C. Wainwright Investment Conference
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies